Portal Veterinary medicinal products

chat
19/05/2022 —
News

Birth control pills for female cats and dogs must be prescribed by a veterinarian

Birth control pills for pets can have serious side effects. They should therefore only be dispensed on prescription by a veterinarian and used in accordance with a number of recommendations.
drapeaux
30/05/2022 —
Event

Informal meeting of the Committee for Veterinary Medicinal Products (CVMP — CMDv)

Public : non
As part of the French Presidency of the Council of the European Union (PFUE), the ANMV organises the biannual meeting of the two main bodies involved in the authorisation process for veterinary medicinal products in Europe from 30 May to 2 June 2022: the Coordinating Group on Mutual and Decentralised Recognition Procedures — Veterinary (CMDv) and the Committee for Medicinal Products for Veterinary Use (CVMP), Expert Group at the European Medicines Agency (EMA).
08/04/2022 —
News

PFUE — European Conference on the Use of Plants in Veterinary Medicine

As part of the French Presidency of the Council of the European Union (PFUE), the French agency for veterinary medicinal products (Anses-ANMV) organised a European conference on the use of plants in veterinary medicine on 29 March. The conference, intended for the competent European authorities, was held remotely and attended 54 participants from outside the Anses.
reunion
12/05/2022 —
News

Meeting of Heads of Agency (HMA) from 4 to 6 May 2022

The French agency for veterinary medicinal products (Anses-ANMV) organised with Ansm (French agency for human medicines) the second meeting of Heads of Agency (HMA) from 4 to 6 May. The meeting was held at the Palais du Grand Large in Saint Malo with 90 participants from the competent European authorities, the European Commission and the European Medicines Agency (EMA). On the first day, a meeting was organised with stakeholders: representatives of the veterinary medicine industry, veterinarians, farmers and the veterinary diagnosis industry. Among other things, the meeting provided an opportunity to discuss the implementation of the Veterinary Regulations. On May 5th and 6th, the heads of medicines agencies met for a day and a half. At the veterinary session, the European strategy HMA-EMA 2021-2025 on “Big Data” was adopted as well as the Action Plan of the Network of Agencies’ 2025 Strategy. Part of this event was dedicated to medical devices for human use.
pharmacovigilance
04/05/2022 —
News

A new process for monitoring adverse reactions to veterinary medicines

A new EU-wide pharmacovigilance scheme has been launched with the new EU Regulation on veterinary medicinal products. It aims to manage the adverse effects of veterinary medicines and applies to all medicines authorised in at least one European Union country. We put three questions on this new process to Sylviane Laurentie, deputy director of the French Agency for Veterinary Medicinal Products, responsible for inspection, surveillance and pharmacovigilance.
Médicaments Vétérinaires
07/03/2022 —
News

Three new databases for greater transparency on veterinary medicinal products in Europe

The new Regulation (EU) No 2019/6 on veterinary medicinal products provides for the creation of three databases, designed to improve access to and sharing of information on these products. Here is an overview of their objectives.
Traitement Hormonaux Humain
21/01/2022 —
Daily life

Human hormonal treatments: be careful not to expose your pets

In dogs and cats, repeated contact with their owner’s topical hormone replacement therapy can cause hormonal problems. Following reports of adverse effects in several European countries, ANSES-ANMV (French Agency for Veterinary Medicinal Products) is inviting owners to apply these medications with the necessary precautions to avoid exposing their pets.
Médicaments vétérinaires
28/01/2022 —
News

What does the new European regulation on veterinary medicinal products change?

The new European regulation on veterinary pharmaceuticals came into force on 28 January 2022. The Director of the French Agency for Veterinary Medicinal Products (ANMV), Jean-Pierre Orand, assesses what will change.
Phytothérapie Aromathérapie
24/01/2022 —
Expert assessment

Phytotherapy and aromatherapy: adapting risk assessment in veterinary medicine

Herbal preparations (phytotherapy) and essential oils (aromatherapy) are increasingly being used as alternatives to other “allopathic” medicinal products for the treatment of animals. This is true even for food-producing animals. If the products used have a therapeutic purpose, they are considered veterinary medicinal products.This means it should be possible to guarantee there is no risk to consumers of foods derived from treated animals. However, it is complicated to implement the current regulations to assess this risk for herbal medicinal products. ANSES therefore issued an internal request to propose a specific assessment methodology for herbal veterinary medicinal products.

Pages